Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Analysis of Vitreo-Macular Adhesion in Diabetic Patients Without Proliferative Retinopathy.

Cureus·2026
Same author

Smartphone fundus photography: Optics revisited.

The National medical journal of India·2026
Same author

Tyrosine Kinase Receptors, Inhibition, and Potential Role in the Pharmacotherapy of Retinal Disorders.

Ophthalmology and therapy·2026
Same author

Pediatric Retinal Vasculitis: Major Review.

Seminars in ophthalmology·2026
Same author

Thermal Melting of a 25-Gauge Chandelier Tip: A Novel Intraoperative Salvage.

Ophthalmology. Retina·2026
Same author

Characterizing morphological variations of feathery cataract using AS-OCT in post-vitrectomy eyes.

Indian journal of ophthalmology·2026
Same journal

Geographic Access to Pediatric Retina Specialists in the United States.

Ophthalmic surgery, lasers & imaging retina·2026
Same journal

Precision-Guided Suprachoroidal Injection Using Ultrasound Biomicroscopy and Custom-Length Microneedles.

Ophthalmic surgery, lasers & imaging retina·2026
Same journal

Metastatic Cutaneous Amelanotic Melanoma to the Vitreous Masquerading as a Fungal Endophthalmitis.

Ophthalmic surgery, lasers & imaging retina·2026
Same journal

Demographic and Prevalence Dynamics of Macular Telangiectasia Type 2 From 2015 to 2024.

Ophthalmic surgery, lasers & imaging retina·2026
Same journal

Alport Syndrome With Wheel-like Bilateral Macular Holes: A Case Report and Literature Review.

Ophthalmic surgery, lasers & imaging retina·2026
Same journal

Trends in the Initial Treatment for Retinopathy of Prematurity in the United States.

Ophthalmic surgery, lasers & imaging retina·2026
See all related articles

Related Experiment Video

Updated: Apr 24, 2026

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

148

Preoperative Intravitreal Viscoelastic Injection (PIVOT) for Surgical Optimization in Rhegmatogenous Retinal

Ritweez Sahu1, Devesh Kumawat1, Ananya Kaginalkar1

  • 1Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Ophthalmic Surgery, Lasers & Imaging Retina
|April 22, 2026
PubMed
Summary
This summary is machine-generated.

Preoperative intravitreal viscoelastic injection (PIVOT) effectively reduces choroidal detachment height before vitrectomy for rhegmatogenous retinal detachment with choroidal detachment (RRDCD). This safe procedure optimizes surgical conditions for complex retinal detachments.

More Related Videos

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

3.8K
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

1.3K

Related Experiment Videos

Last Updated: Apr 24, 2026

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

148
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

3.8K
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

1.3K

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Vitreoretinal Interface

Background:

  • Rhegmatogenous retinal detachment with choroidal detachment (RRDCD) presents significant surgical challenges.
  • Effective management strategies for RRDCD are crucial for successful visual outcomes.

Purpose of the Study:

  • To evaluate the safety and efficacy of preoperative intravitreal viscoelastic injection (PIVOT) in facilitating vitrectomy for RRDCD.
  • To assess the impact of PIVOT on intraocular pressure and choroidal detachment height.

Main Methods:

  • A consecutive series of eight eyes with RRDCD underwent PIVOT using Healon™ PRO (1% sodium hyaluronate) prior to vitrectomy.
  • Concurrent treatment included topical difluprednate, cycloplegics, and oral corticosteroids.
  • Outcome measures included intraocular pressure (IOP), cumulative choroidal detachment (CD) height, and adverse events.

Main Results:

  • Mean IOP increased significantly from baseline (4.75 ± 2.05 mmHg) to the day of surgery (10.0 ± 3.34 mmHg) (P = .001).
  • Cumulative CD height significantly reduced from 15.82 ± 4.88 mm to 5.49 ± 6.01 mm (P = .003).
  • No injection-related adverse events or intraoperative complications were reported; vitrectomy was completed successfully.

Conclusions:

  • PIVOT, in conjunction with anti-inflammatory therapy, demonstrates safety and efficacy in managing RRDCD.
  • This approach optimizes surgical conditions, facilitating successful vitrectomy in complex retinal detachment cases.